Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Epirubicin MeSH Descriptor Data 2025


MeSH Heading
Epirubicin
Tree Number(s)
D02.455.426.559.847.562.050.200.175.200
D04.615.562.050.200.175.200
D09.408.051.059.200.175.200
Unique ID
D015251
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015251
Scope Note
An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.
Entry Term(s)
4'-Epi-Adriamycin
4'-Epi-DXR
4'-Epi-Doxorubicin
4'-Epiadriamycin
4'-Epidoxorubicin
EPI-cell
Ellence
Epilem
Epirubicin Hydrochloride
Farmorubicin
Farmorubicina
Farmorubicine
IMI-28
NSC-256942
Pharmorubicin
Pharm Action
Antibiotics, Antineoplastic
Topoisomerase II Inhibitors
Registry Numbers
3Z8479ZZ5X
0
22966TX7J5
Related Numbers
22966TX7J5
56390-09-1
56420-45-2
CAS Type 1 Name
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
Previous Indexing
Doxorubicin (1973-1988)
Public MeSH Note
89
History Note
89
Date Established
1989/01/01
Date of Entry
1988/05/16
Revision Date
2016/07/01
Epirubicin Preferred
Ellence Narrower
Epirubicin Hydrochloride Narrower
IMI-28 Narrower
NSC-256942 Narrower
Epilem Narrower
EPI-cell Narrower
Farmorubicina Narrower
page delivered in 0.126s